OOIR: Observatory of International Research

Papers

(The median citation count of Journal of Benefit-Cost Analysis is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
The Cost-Benefit Fallacy: Why Cost-Benefit Analysis Is Broken and How to Fix It	37
Incidence and Costs of Personal and Property Crimes in the USA, 2017	27
The Value of Statistical Life: A Meta-Analysis of Meta-Analyses	24
The Generalized Risk-Adjusted Cost-Effectiveness (GRACE) Model for Measuring the Value of Gains in Health: An Exact Formulation	13
Accounting for the Distribution of Benefits and Costs in Benefit–Cost Analysis	13
Extending the Domain of the Value of a Statistical Life	11
Addressing Fundamental Uncertainty in Benefit–Cost Analysis: The Case of Deep Seabed Mining	10
Economic Activity and the Value of Medical Innovation during a Pandemic	10
The Welfare Cost of Vaccine Misallocation, Delays and Nationalism	8
How is the U.S. Pricing Carbon? How Could We Price Carbon?	8
Valuing COVID-19 Morbidity Risk Reductions	8
The Benefits and Costs of a Child Allowance	8
Economic Evaluation of Investments in Airports: Recent Developments	7
Early Education and Adult Health: Age 37 Impacts and Economic Benefits of the Child-Parent Center Preschool Program	7
Promoting Equity through Equitable Risk Tradeoffs	6
Time Savings vs. Access-Based Benefit Assessment of New York’s Second Avenue Subway	6
Open Access in Scientific Information: Sustainability Model and Business Plan for the Infrastructure and Organization of OpenAIRE	5
Accounting for the Effects of Employment, Equity, and Risk Aversion in Cost–Benefit Analysis: An Application to an Adaptation Project	5
Benefit-Cost Ratios of Continuing Routine Immunization During the COVID-19 Pandemic in Africa	5
Distributional weighting and welfare/equity tradeoffs: a new approach	5
Improving Learning in Low- and Lower-Middle-Income Countries	4
Discounting in Natural Resource Damage Assessment	4
The Broad Impacts of Disposable Lighter Safety Regulations	3
Inequality and the Value of a Statistical Life	3
Paying a Premium for “Green Steel”: Paying for an Illusion?	3

An Equity Blindspot: The Incidence of Regulatory Costs	3
The Weak Spot of Infrastructure BCA: Cost Overruns in Seven Road and Railway Construction Projects	3
Risk-Informed Benefit–Cost Analysis for Homeland Security R&D: Methodology and an Application to Evaluating the Advanced Personal Protection System for Wildland Firefighters	3
Quantifying the Non-Use Value of Biodiversity in Cost–Benefit Analysis: The Dutch Biodiversity Points	3
A Benefit-Cost Analysis of Increased International Migration of Skilled Labor in Africa and the World	3
Is California’s Electric Vehicle Rebate Regressive? A Distributional Analysis	3
Cost–Benefit Assessment of Public Investments in France: The Use of Counter-Experts	3
Costs and Benefits of Branded Drugs: Insights from Cost-Effectiveness Research	3
The Elasticity of Marginal Utility of Income for Distributional Weighting and Social Discounting: A Meta-Analysis	3
Benefit-Cost Analysis for Climate Action	3
The Investment Case for Land Tenure Security in Sub-Saharan Africa: A Cost–Benefit Analysis	3
Demand for an Environmental Public Good in the Time of COVID-19: A Statewide Water Quality Referendum	2
One Million Lives Saved Per Year: A Cost–Benefit Analysis of the Global Plan to End Tuberculosis, 2023–2030 and Beyond	2
Dynamic Versus Static Modeling of Mortality-Related Benefits of PM_2.5 Reductions in the USA and Chile: 1990 to 2050	2
Benefit–Cost Analysis of Increased Funding for Agricultural Research and Development in the Global South	2
A Test of Hirschman’s Hiding Hand Principle in World Bank-Financed Hydropower Projects	2
Sustainable Development Goal Halftime Project: Benefit-Cost Analysis Using Methods from the Decade of Vaccine Economics Model	2
Distribution and Disputation: Net Benefits, Equity, and Public Decision-Making	2
Best Investments in Chronic, Noncommunicable Disease Prevention and Control in Low- and Lower–Middle-Income Countries	2
Seven Recommendations for Pricing Greenhouse Gas Emissions	2
The Investment Case for E-Government Procurement: A Cost–Benefit Analysis	2
Methodological Challenges in Estimating the Lifetime Medical Care Cost Externality of Obesity	2
Achieving Maternal and Neonatal Mortality Development Goals Effectively: A Cost-Benefit Analysis	2
The Influence of Individual Characteristics and Institutional Norms on Bureaucrats’ Use of Cost–Benefit Analysis: A Choice Experiment	2
Three Criteria for Evaluating Social Programs	2
Investing in Nutrition: A Global Best Investment Case	1
When Can Benefit–Cost Analyses Ignore Secondary Markets?	1
Benefit–Cost Analysis of Increased Trade: An Order-of-Magnitude Estimate of the Benefit–Cost Ratio	1
Regulators Should Value Nonhuman Animals	1
The Benefits and Costs of Automotive Regulations for Low-Income Americans	1
All Cancers Are not Created Equal: How Do Survival Prospects Affect the Willingness to Pay to Avoid Cancer?	1
Poverty, Irrationality, and the Value of Cash Transfers	1
Estimating Lost Dividends from Incomplete Energy Access Transitions	1
Benefit–Cost Analysis of Social Media Facilitated Bystander Programs	1
“We Test”: An Imagined Regulatory Future	1
Institutional Roles and Goals for Retrospective Regulatory Analysis	1